Swissmedic issues Botox warning

The Swiss authorities have issued a warning about the harmful side effects of the "anti-wrinkle" treatment known as Botox.

This content was published on June 12, 2008 - 10:13

The supervisory agency, Swissmedic, said there had been an increased problem with the non-controlled use of products using the active substance, botulinum toxin, in cosmetic "off-label use".

This means the use of medicines for purposes outside the scope of what is permitted in the information relating to the medicine.

The muscle-paralysing effect of type A botulinum toxin is increasingly used in Switzerland for cosmetic treatment of skin wrinkles.

Its use for this purpose is frequently and falsely claimed by commercial suppliers to be a simple, uncomplicated cosmetic treatment by means of an extremely minor procedure, Swissmedic said on Thursday.

Referring to reports by the United States Food and Drug Administration (FDA), Swissmedic said the product could spread and lead to problems with swallowing and breathing if applied to the throat area.

If large quantities reach the bloodstream, paralysis may occur, it said. In the worst case, there is danger of suffocation.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.